Osteopore Limited (ASX:OSX)
0.0120
+0.0020 (20.00%)
Aug 29, 2025, 3:50 PM AEST
Osteopore Revenue
Osteopore had revenue of 1.29M AUD in the half year ending December 31, 2024, with 46.83% growth. This brings the company's revenue in the last twelve months to 2.85M, up 5.52% year-over-year. In the year 2024, Osteopore had annual revenue of 2.76M with 24.60% growth.
Revenue (ttm)
2.85M
Revenue Growth
+5.52%
P/S Ratio
1.00
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.85M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.76M | 545.37K | 24.60% |
Dec 31, 2023 | 2.22M | 525.02K | 31.02% |
Dec 31, 2022 | 1.69M | 579.38K | 52.06% |
Dec 31, 2021 | 1.11M | -391.57K | -26.03% |
Dec 31, 2020 | 1.50M | 1.09M | 265.54% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 23.73B |
Pro Medicus | 212.98M |
Cochlear | 2.34B |
Sonic Healthcare | 9.65B |
Ramsay Health Care | 17.12B |
Telix Pharmaceuticals | 1.01B |
Ansell | 3.06B |
Mesoblast | 26.23M |